A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer

Conditions

• Breast Neoplasms

Interventions

• DRUG: TC-H x Paclitaxel (P) + Trastuzumab(T)

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Collaborators

• [object Object]